SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    M.A. Cerqueira, W.W. Laranja, B.C.F. Sanches, C.R. Monti, L.O. Reis, Burden of focal cryoablation versus brachytherapy versus active surveillance in the treatment of very low-risk prostate cancer: a preliminary head-to-head comprehensive assessment, European Journal of Cancer Care, 2015, 24,
  2. 2
    Erica H. Lee, Rajiv I. Nijhawan, Kishwer S. Nehal, Stephen W. Dusza, Amanda Levine, Amanda Hill, Christopher A. Barker, Comorbidity Assessment in Skin Cancer Patients: A Pilot Study Comparing Medical Interview with a Patient-Reported Questionnaire, Journal of Skin Cancer, 2015, 2015, 1

    CrossRef

  3. 3
    Jeanne T Black, Patrick S Romano, Banafsheh Sadeghi, Andrew D Auerbach, Theodore G Ganiats, Sheldon Greenfield, Sherrie H Kaplan, Michael K Ong, A remote monitoring and telephone nurse coaching intervention to reduce readmissions among patients with heart failure: study protocol for the Better Effectiveness After Transition - Heart Failure (BEAT-HF) randomized controlled trial, Trials, 2014, 15, 1, 124

    CrossRef

  4. 4
    Parul Sinha, Dorina Kallogjeri, Jay F. Piccirillo, Assessment of comorbidities in surgical oncology outcomes, Journal of Surgical Oncology, 2014, 110, 5
  5. 5
    Matthew J. Resnick, Daniel A. Barocas, Alicia K. Morgans, Sharon E. Phillips, Vivien W. Chen, Matthew R. Cooperberg, Michael Goodman, Sheldon Greenfield, Ann S. Hamilton, Karen E. Hoffman, Sherri H. Kaplan, Lisa E. Paddock, Antoinette M. Stroup, Xiao-Cheng Wu, Tatsuki Koyama, David F. Penson, Contemporary prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction: Defining the population at risk for harms of prostate cancer treatment, Cancer, 2014, 120, 8
  6. You have free access to this content6
    Bryce B. Reeve, Ronald C. Chen, Dominic T. Moore, Allison M. Deal, Deborah S. Usinger, Jessica C. Lyons, James A. Talcott, Impact of comorbidity on health-related quality of life after prostate cancer treatment: combined analysis of two prospective cohort studies, BJU International, 2014, 114, 6b
  7. 7
    Jonathan Bergman, Aaron Laviana, Quality-of-life assessment tools for men with prostate cancer, Nature Reviews Urology, 2014, 11, 6, 352

    CrossRef

  8. 8
    Richard M Hoffman, David F Penson, Anthony L Zietman, Michael J Barry, Comparative effectiveness research in localized prostate cancer treatment, Journal of Comparative Effectiveness Research, 2013, 2, 6, 583

    CrossRef

  9. 9
    Michael A. Liss, John Billimek, Kathryn Osann, Jane Cho, Ross Moskowitz, Adam Kaplan, Richard J. Szabo, Sherrie H. Kaplan, Sheldon Greenfield, Atreya Dash, Consideration of comorbidity in risk stratification prior to prostate biopsy, Cancer, 2013, 119, 13
  10. 10
    R. M. Hoffman, T. Koyama, K.-H. Fan, P. C. Albertsen, M. J. Barry, M. Goodman, A. S. Hamilton, A. L. Potosky, J. L. Stanford, A. M. Stroup, D. F. Penson, Mortality After Radical Prostatectomy or External Beam Radiotherapy for Localized Prostate Cancer, JNCI Journal of the National Cancer Institute, 2013, 105, 10, 711

    CrossRef

  11. 11
    Shaista Malik, John Billimek, Sheldon Greenfield, Dara H. Sorkin, Quyen Ngo-Metzger, Sherrie H. Kaplan, Patient Complexity and Risk Factor Control Among Multimorbid Patients With Type 2 Diabetes, Medical Care, 2013, 51, 2, 180

    CrossRef

  12. 12
    Annelies Vellekoop, Stacy Loeb, The Utility of Prostate-Specific Antigen Screening and Prostate Cancer Treatment in Elderly Patients, Current Translational Geriatrics and Experimental Gerontology Reports, 2013, 2, 2, 51

    CrossRef

  13. 13
    Sheldon Greenfield, Sherrie H Kaplan, Building useful evidence: changing the clinical research paradigm to account for comparative effectiveness research, Journal of Comparative Effectiveness Research, 2012, 1, 3, 263

    CrossRef

  14. You have free access to this content14
    Robert (‘Frank’) A. Gardiner, John Yaxley, Peter D. Baade, Integrating disparate snippets of information in an approach to PSA testing in Australia and New Zealand, BJU International, 2012, 110,
  15. 15
    Jordan A. Holmes, Andrew Z. Wang, Karen E. Hoffman, Laura H. Hendrix, Julian G. Rosenman, William R. Carpenter, Paul A. Godley, Ronald C. Chen, Is Primary Prostate Cancer Treatment Influenced by Likelihood of Extraprostatic Disease? A Surveillance, Epidemiology and End Results Patterns of Care Study, International Journal of Radiation Oncology*Biology*Physics, 2012, 84, 1, 88

    CrossRef

  16. 16
    Karen E. Hoffman, Management of Older Men With Clinically Localized Prostate Cancer: The Significance of Advanced Age and Comorbidity, Seminars in Radiation Oncology, 2012, 22, 4, 284

    CrossRef

  17. 17
    Mark S. Litwin, Campbell-Walsh Urology, 2012,

    CrossRef

  18. 18
    Timothy J. Daskivich, Karim Chamie, Lorna Kwan, Jessica Labo, Atreya Dash, Sheldon Greenfield, Mark S. Litwin, Comorbidity and competing risks for mortality in men with prostate cancer, Cancer, 2011, 117, 20
  19. 19
    Takashi YAMASHITA, Cary S. KART, Is diabetes-specific health literacy associated with diabetes-related outcomes in older adults?, Journal of Diabetes, 2011, 3, 2
  20. 20
    Neda Laiteerapong, Elbert S. Huang, Marshall H. Chin, Prioritization of care in adults with diabetes and comorbidity, Annals of the New York Academy of Sciences, 2011, 1243, 1
  21. 21
    Matthew R. Cooperberg, Andrew J. Vickers, Jeanette M. Broering, Peter R. Carroll, Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer, Cancer, 2010, 116, 22
  22. 22
    T J Daskivich, L V van de Poll-Franse, L Kwan, N Sadetsky, D M Stein, M S Litwin, From bad to worse: comorbidity severity and quality of life after treatment for early-stage prostate cancer, Prostate Cancer and Prostatic Diseases, 2010, 13, 4, 320

    CrossRef

  23. 23
    Seth A. Strope, Zaojun Ye, John M. Hollingsworth, Brent K. Hollenbeck, Patterns of care for early stage bladder cancer, Cancer, 2010, 116, 11
  24. 24
    Thomas J. Guzzo, Paul Dluzniewski, Ryan Orosco, Elizabeth A. Platz, Alan W. Partin, Misop Han, Prediction of Mortality After Radical Prostatectomy by Charlson Comorbidity Index, Urology, 2010, 76, 3, 553

    CrossRef

  25. 25
    Sherrie H. Kaplan, John Billimek, Dara H. Sorkin, Quyen Ngo-Metzger, Sheldon Greenfield, Who Can Respond to Treatment?, Medical Care, 2010, 48, S9

    CrossRef

  26. 26
    B G Druss, I Hwang, M Petukhova, N A Sampson, P S Wang, R C Kessler, Impairment in role functioning in mental and chronic medical disorders in the United States: results from the National Comorbidity Survey Replication, Molecular Psychiatry, 2009, 14, 7, 728

    CrossRef

  27. 27
    Sherrie H. Kaplan, John L. Griffith, Lori L. Price, L Gregory Pawlson, Sheldon Greenfield, Improving the Reliability of Physician Performance Assessment, Medical Care, 2009, 47, 4, 378

    CrossRef

  28. 28
    Y. Neuzillet, L’évaluation des morbidités compétitives et des scores d’évaluation de la morbidité compétitive, Progrès en Urologie, 2009, 19, S80

    CrossRef

  29. 29
    Mark Soloway, Low-risk prostate cancer and low testosterone: What are the acceptable alternatives?, Current Urology Reports, 2009, 10, 6, 413

    CrossRef

  30. 30
    Natalia Sadetsky, Alan Hubbard, Peter R. Carroll, William Satariano, Predictive value of serial measurements of quality of life on all-cause mortality in prostate cancer patients: data from CaPSURE™ (cancer of the prostate strategic urologic research endeavor) database, Quality of Life Research, 2009, 18, 8, 1019

    CrossRef

  31. 31
    Y. Neuzillet, A. Méjean, T. Lebret, Évaluation oncogériatrique du sujet âgé ayant un cancer urologique métastatique, Progrès en Urologie, 2008, 18, S415

    CrossRef

  32. 32
    Cynthia M. Boyd, Christine S. Ritchie, Edmond F. Tipton, Stephanie A. Studenski, Darryl Wieland, From Bedside to Bench: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Comorbidity and Multiple Morbidity in Older Adults, Aging Clinical and Experimental Research, 2008, 20, 3, 181

    CrossRef

  33. 33
    Mark S. Litwin, Health Services Research, Seminars in Radiation Oncology, 2008, 18, 3, 152

    CrossRef

  34. 34
    Shabbir M. H. Alibhai, Marc Leach, George A. Tomlinson, Murray D. Krahn, Neil E. Fleshner, Gary Naglie, Is there an optimal comorbidity index for prostate cancer?, Cancer, 2008, 112, 5
  35. 35
    Tommaso Cai, Riccardo Bartoletti, Is There an Optimal Comorbidity Index for Prostate Cancer?, Cancer, 2008, 113, 5
  36. 36
    Lonneke V. van de Poll-Franse, Natalia Sadetsky, Lorna Kwan, Mark S. Litwin, Severity of cardiovascular disease and health-related quality of life in men with prostate cancer: a longitudinal analysis from CaPSURE, Quality of Life Research, 2008, 17, 6, 845

    CrossRef

  37. 37
    Lonneke V. van de Poll-Franse, Lorna Kwan, Robert E. Reiter, Steve P. Lee, Mark S. Litwin, The Influence of Cardiovascular Disease on Health Related Quality of Life in Men With Prostate Cancer: A 4-Year Followup Study, The Journal of Urology, 2008, 179, 4, 1362

    CrossRef

  38. 38
    Mark A Suckow, Julie Heinrich, Elliot D Rosen, Tissue vaccines for cancer, Expert Review of Vaccines, 2007, 6, 6, 925

    CrossRef